← Back to Search

Behavioral Intervention

Study population for Cardiometabolic Syndrome

N/A

Recruiting

Led By Andrea Lopez-Cepero, PhD

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, week 4

Awards & highlights

Study Summary

This trial aims to see if a 4-week mindfulness program is feasible and well-received by young women in Puerto Rico experiencing high levels of stress. It will also investigate how the program affects participants'

Who is the study for?

This trial is for young women in Puerto Rico who are experiencing high levels of stress and may have cardiometabolic syndrome or metabolic issues. Participants should be willing to attend weekly virtual mindfulness sessions, do daily exercises at home, and fill out online questionnaires.Check my eligibility

What is being tested?

The study is testing a 4-week virtual mindfulness-based stress reduction program. It aims to see if this program is practical and well-received by the participants while measuring changes in their psychological resilience, distress, health behaviors, and markers related to heart health and metabolism.See study design

What are the potential side effects?

Since the intervention involves non-invasive practices like mindfulness exercises, significant side effects are not expected. However, some individuals might experience increased emotional sensitivity or mild discomfort as they engage with their thoughts during practice.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, week 4

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, week 4

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 4 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence to the program

Rates of recruitment and retention

Ratings of satisfaction

Secondary outcome measures

Change in cardiometabolic markers: Blood Pressure

Change in cardiometabolic markers: Waist Circumference

Change in cardiometabolic markers: Weight

Trial Design

1Treatment groups

Experimental Treatment

Group I: Study populationExperimental Treatment2 Interventions

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Home exercises

2016

N/A

~340

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH

484 Previous Clinical Trials

1,086,815 Total Patients Enrolled

Emory UniversityLead Sponsor

1,640 Previous Clinical Trials

2,560,666 Total Patients Enrolled

Andrea Lopez-Cepero, PhDPrincipal InvestigatorRollins School of Public Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available positions for patients in this ongoing clinical trial?

"Information sourced from clinicaltrials.gov reveals that this research investigation is currently in the recruitment phase. This trial was initially published on 2/2/2024 and last revised on 2/1/2024."

Answered by AI

What is the upper limit on the number of participants enrolled in this medical study?

"Indeed, the details on clinicaltrials.gov reveal that this particular medical research is actively seeking participants. The initial posting date for this trial was February 2nd, 2024, and it was last revised on February 1st of the same year. Recruitment aims to enlist a total of 30 patients from one designated site."

Answered by AI